Abstract
RON, a member of the MET proto-oncogene family, has been implicated in the progression of certain epithelial cancers. The purpose of this study was to determine the oncogenic potential of RON in vivo in lung epithelial cells. Transgenic mice were established using surfactant protein C promoter to express human RON in the distal lung epithelial cells. These mice were born normal but developed multiple lung tumors with distinct morphology and growth patterns. Tumors appeared as a single mass in the lung around 2 months of age and gradually developed into multiple nodules located mostly in the peripheral portions of the lung. A transition from early adenomas to later adenocarcinomas was observed. Morphologically, tumors were characterized as cuboidal epithelial cells with a type II cell phenotype, grew along the alveolar walls, and projected into the alveolar septa. RON was highly expressed and constitutively activated in tumors. These results indicate that overexpression of human wild-type RON causes the formation of lung tumors with unique biological characteristics in vivo. This model provides opportunities to study the role of RON in the pathogenesis of lung tumors and to elucidate the mechanisms underlying this distinct lung tumor.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Angeloni D, Danilkovitch-Miagkova A, Ivanov SV, Breathnach R, Johnson BE, Leonard EJ, Lerman MI . 2000 Genes Chrom. Cancer 29: 147–156
Chen Y-Q, Zhou Y-Q, Angeloni D, Kurtz AL, Qiang X-Z, Wang M-H . 2000 Exp. Cell Res. 261: 229–238
Clark JC, Tichelaar JW, Wert SE, Itoh N, Perl A-KT, Stahlman MT, Whitsett JA . 2001 Am. J. Physiol. Lung Cell Mol. Physiol. 280: L705–L715
Gaudino G, Avantaggiato V, Follenzi A, Acampora D, Simeone A, Comoglio PM . 1995 Oncogene 11: 2627–2637
Gaudino G, Follenzi A, Naldini L, Collesi C, Santoro M, Gallo KA, Godowski PJ, Comoglio PM . 1994 EMBO J. 13: 3524–3532
Glasser SW, Korfhagen TR, Bruno MD, Dey C, Whitsett JA . 1990 J. Biol. Chem. 265: 21986–21991
Han S, Stuart LA, Degen SJF . 1991 Biochemistry 30: 9768–9780
Ho Y-S, Vincent R, Dey MS, Slot JW, Crapo JD . 1998 Am. J. Respir. Cell. Mol. Biol. 18: 538–547
Hogan BF, Constantiti F, Lacy E . 1996 Manipulating the Mouse Embryo Cold Spring Harbor, NY: Cold Spring Harbor Laboratory
Iwama A, Okano K, Sudo T, Matsuda Y, Suda T . 1994 Blood 83: 3160–3169
Kerkhoff E, Fedorov LM, Siefken R, Walter AO, Papadopoulos T, Rapp UR . 2000 Cell Growth Differ. 11: 185–190
Lavigueur A, Maltby V, Mock D, Rossant J, Pawson T, Bernstein A . 1989 Mol. Cell Biol. 9: 3982–3991
Lebel M, Webster M, Muller W, Royal A, Gauthier J, Mes-Masson A-M . 1995 Cell Growth Differ. 6: 1591–1600
Li B, Wang M-H, Kung H-F, Ronsin C, Breathnach R, Leonard EJ, Kamata T . 1995 Biochem. Biophys. Res. Commun. 216: 110–118
Maggiora P, Marchio S, Stella MC, Giai M, Belfiore A, De Bortoli M, Di Renzo MF, Costantino A, Sismondi P, Comoglio PM . 1998 Oncogene 16: 2927–2933
Malkinson AM . 1998 Exp. Lung Res. 24: 541–555
Mason RJ, Kalina M, Nielsen LD, Malkinson AM, Shannon JM . 2000 Am. J. Pathol. 156: 175–182
Muraoka RS, Sun WS, Colbert MC, Waltz SE, Witte DP, Degen JL, Degen SJF . 1999 J. Clin. Invest. 103: 1277–1285
Ronsin C, Muscatelli F, Mattei MG, Breathnach R . 1993 Oncogene 8: 1195–1202
Sakamoto O, Iwama A, Amitani R, Takehara T, Yamaguchi N, Yamamoto T, Masuyama K, Yamanaka T, Ando M, Suda T . 1997 J. Clin. Invest. 99: 701–709
Sandmoeller A, Halter R, Suske G, Beato M . 1995 Cell Growth Differ. 6: 97–103
Santoro MM, Collesi C, Grisendi S, Gaudino G, Comoglio PM . 1996 Mol. Cell. Biol. 16: 7072–7083
Santoro MM, Penengo L, Minetto M, Orecchia S, Cilli M, Gadino G . 1998 Oncogene 17: 741–749
Singh G, Katyal S . 1998 Am. J. Respir. Cell Mol. 17: 141–143
Skeel A, Yoshimura T, Showalter SD, Tanaka S, Appella E, Leonard EJ . 1991 J. Exp. Med. 173: 1227–1234
Wang M-H, Ronsin C, Gesnel MC, Coupeym L, Skeel A, Leonard EJ, Breathnach R . 1994 Science 266: 117–119
Wang M-H, Montero-Julian FA, Leonard EJ . 1996 Oncogene 13: 2167–2175
Wikenheiser KA, Clark JC, Linnoila I, Stahlman MT, Whitsett JA . 1992 Cancer Res. 52: 5342–5352
Willett C, Wang M-H, Emanuel RL, Graham SA, Smith DI, Shridhar V, Sugarbaker DJ, Sunday M . 1998 Am. J. Respir. Cell Mol. Biol. 18: 489–496
Willett CG, Smith DI, Shridhar V, Wang M-H, Emanuel R, Patidar K, Graham SA, Zhang F, Hatch V, Sugarbaker JD, Sunday ME . 1997 J. Clin. Invest. 99: 2979–2991
Acknowledgements
We thank Drs JA Whitsett (University of Cincinnati, Cincinnati, OH, USA) for the 3.7SPC/SV40 vector, G Singh (Department of Veterans Affairs Medical Center, Pittsburgh, PA, USA) for antibodies to CC10 and proSPC, and W Gunning (Medical College of Ohio, Toledo, OH, USA) for histological examination. We are indebted to Dr Y-S Ho for his kind help in the generation of the transgenic mice. This work was supported by NIH Grants RO1 AI43516 and CA91980 to M-H Wang.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, YQ., Zhou, YQ., Fisher, J. et al. Targeted expression of the receptor tyrosine kinase RON in distal lung epithelial cells results in multiple tumor formation: oncogenic potential of RON in vivo. Oncogene 21, 6382–6386 (2002). https://doi.org/10.1038/sj.onc.1205783
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205783
Keywords
This article is cited by
-
Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors
Investigational New Drugs (2017)
-
MSP–RON signalling in cancer: pathogenesis and therapeutic potential
Nature Reviews Cancer (2013)
-
The monoclonal antibody Zt/f2 targeting RON receptor tyrosine kinase as potential therapeutics against tumor growth-mediated by colon cancer cells
Molecular Cancer (2011)
-
The Ron receptor promotes prostate tumor growth in the TRAMP mouse model
Oncogene (2011)
-
Lungenkrebs: vom Gen zur Therapie
Onkopipeline (2010)